Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James Hamilton

Showing results (111-120 of 122) with videos related to

Pageof 13
Sort By:
Oncogene|April 13, 2005
Inactivation of p16, RUNX3, and HPP1 occurs early in Barrett's-associated neoplastic progression and predicts progression riskKarsten Schulmann, Anca Sterian, Agnes Berki, et al.
American Journal of Physiology. Endocrinology and Metabolism|January 16, 2019
Loss of <i>Nmp4</i> optimizes osteogenic metabolism and secretion to enhance bone qualityYu Shao, Emily Wichern, Paul J Childress, et al.
Journal of Hepatology|December 13, 2022
A phase I/II study of ARO-HSD, an RNA interference therapeutic, for the treatment of non-alcoholic steatohepatitisLung-Yi Mak, Ed Gane, Christian Schwabe, et al.
Journal of Hepatology|July 23, 2022
Combination treatments including the small-interfering RNA JNJ-3989 induce rapid and sometimes prolonged viral responses in patients with CHBMan-Fung Yuen, Stephen Locarnini, Tien Huey Lim, et al.
Gastroenterology|July 4, 2024
Fazirsiran for Adults With Alpha-1 Antitrypsin Deficiency Liver Disease: A Phase 2 Placebo Controlled Trial (SEQUOIA)Virginia C Clark, Charlie Strange, Pavel Strnad, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 3, 2022
HIF2 Inactivation and Tumor Suppression with a Tumor-Directed RNA-Silencing Drug in Mice and HumansYuanqing Ma, Allison Joyce, Olivia Brandenburg, et al.
Plos Genetics|January 15, 2010
Genome-wide association study identifies ALDH7A1 as a novel susceptibility gene for osteoporosisYan Guo, Li-Jun Tan, Shu-Feng Lei, et al.
Circulation|November 2, 2022
2022 ACC/AHA Guideline for the Diagnosis and Management of Aortic Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice GuidelinesEric M Isselbacher, Ourania Preventza, James Hamilton Black, et al.
Journal of the American College of Cardiology|November 5, 2022
2022 ACC/AHA Guideline for the Diagnosis and Management of Aortic Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines, Eric M Isselbacher, Ourania Preventza, et al.
Cancer Cell|December 30, 2022
Determinants of resistance to engineered T cell therapies targeting CD19 in large B cell lymphomasBrian J Sworder, David M Kurtz, Stefan K Alig, et al.
Pageof 13

Showing results (111-120 of 122) with videos related to

Sort By:
Pageof 13
Oncogene|April 13, 2005
Inactivation of p16, RUNX3, and HPP1 occurs early in Barrett's-associated neoplastic progression and predicts progression riskKarsten Schulmann, Anca Sterian, Agnes Berki, et al.
American Journal of Physiology. Endocrinology and Metabolism|January 16, 2019
Loss of <i>Nmp4</i> optimizes osteogenic metabolism and secretion to enhance bone qualityYu Shao, Emily Wichern, Paul J Childress, et al.
Journal of Hepatology|December 13, 2022
A phase I/II study of ARO-HSD, an RNA interference therapeutic, for the treatment of non-alcoholic steatohepatitisLung-Yi Mak, Ed Gane, Christian Schwabe, et al.
Journal of Hepatology|July 23, 2022
Combination treatments including the small-interfering RNA JNJ-3989 induce rapid and sometimes prolonged viral responses in patients with CHBMan-Fung Yuen, Stephen Locarnini, Tien Huey Lim, et al.
Gastroenterology|July 4, 2024
Fazirsiran for Adults With Alpha-1 Antitrypsin Deficiency Liver Disease: A Phase 2 Placebo Controlled Trial (SEQUOIA)Virginia C Clark, Charlie Strange, Pavel Strnad, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 3, 2022
HIF2 Inactivation and Tumor Suppression with a Tumor-Directed RNA-Silencing Drug in Mice and HumansYuanqing Ma, Allison Joyce, Olivia Brandenburg, et al.
Plos Genetics|January 15, 2010
Genome-wide association study identifies ALDH7A1 as a novel susceptibility gene for osteoporosisYan Guo, Li-Jun Tan, Shu-Feng Lei, et al.
Circulation|November 2, 2022
2022 ACC/AHA Guideline for the Diagnosis and Management of Aortic Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice GuidelinesEric M Isselbacher, Ourania Preventza, James Hamilton Black, et al.
Journal of the American College of Cardiology|November 5, 2022
2022 ACC/AHA Guideline for the Diagnosis and Management of Aortic Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines, Eric M Isselbacher, Ourania Preventza, et al.
Cancer Cell|December 30, 2022
Determinants of resistance to engineered T cell therapies targeting CD19 in large B cell lymphomasBrian J Sworder, David M Kurtz, Stefan K Alig, et al.
Pageof 13